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It is well documented that deficiency in ataxia telangiectasia mutated (ATM) protein 
leads to elevated frequency of chromosome translocation, however, it remains poorly 
understood how ATM suppresses translocation frequency. In the present study, we 
addressed the mechanism of ATM-dependent suppression of translocation frequency. To 
know frequency of translocation events in a whole genome at once, we performed 
centromere/telomere FISH and scored dicentric chromosomes, because dicentric and 
translocation occur with equal frequency and by identical mechanism. By 
centromere/telomere FISH analysis, we confirmed that chemical inhibition or 
RNAi-mediated knockdown of ATM causes 2~2.5-fold increase in dicentric frequency 
at first mitosis after 2 Gy of gamma-irradiation in G0/G1. The FISH analysis revealed 
that ATM/p53-dependent G1 checkpoint suppresses dicentric frequency, since 
RNAi-mediated knockdown of p53 elevated dicentric frequency by 1.5-fold. We found 
ATM also suppresses dicentric occurrence independently of its checkpoint role, as ATM 
inhibitor showed additional effect on dicentric frequency in the context of p53 depletion 
and Chk1/2 inactivation. Epistasis analysis using chemical inhibitors revealed that ATM 
kinase functions in the same pathway that requires kinase activity of DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs) to suppress dicentric frequency. From the 
results in the present study, we conclude that ATM minimizes translocation frequency 
through its commitment to G1 checkpoint and DNA double-strand break repair pathway 















     Recurrent chromosome translocation is implicated in a variety of human diseases, 
including many hematopoietic malignancies and some type of solid cancers, e.g. 
prostate cancer [1]. Translocation is generated by incorrect repair between DNA 
double-strand breaks (DSBs) occurring on two or more chromosomes [2]. Translocation 
can form hyperactivated fusion gene products, e.g. BCR-ABL, or lead to overexpression 
of protooncogenes, e.g. c-myc, when the coding sequence of a protooncogene is fused 
to strong enhancer or promoter, e.g. the enhancer of an immunoglobulin gene [1]. 
Moreover, translocation is inheritable through generations, which means alteration of 
genetic information and gene expression is stably transduced to progeny cells [1, 2]. 
Therefore, minimization of translocation formation or its inheritance is critical for 
genome integrity and ordered expression of transcriptome and proteome.  
     It is well documented that deficiency of ataxia telangiectasia mutated (ATM) 
protein is associated with elevated frequency of translocation both in human and mouse 
models [3-5]. ATM is a serine/threonine kinase which belongs to phosphoinositide 
3-kinase (PI3K)-related protein kinase (PIKK) family [6]. ATM plays a pivotal role in 
cellular and molecular response to DSBs, such as cell cycle checkpoint and DSB repair 
[6, 7]. In G1 checkpoint, ATM transduces DSB signals to Chk2 and p53 by 
phosphorylation, and induces transient delay of S phase entry at earlier times and more 
sustained blockage of S phase entry at later times, respectively [8-10]. In intra-S 
checkpoint, Chk1, in cooperation with ATM-activated Chk2, is involved in 
phosphorylation and subsequent degradation of cdc25A, a phosphatase that 
dephosphorylates and activates cyclin-dependent kinase 2 (cdk2) [8, 9]. There is another 
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branch of intra-S checkpoint, which is dependent on NBS1, BRCA1 and SMC1 [8, 11]. 
This pathway also requires ATM-dependent phosphorylation of the above proteins [8, 
11]. In G2 checkpoint, both ATM-Chk2 pathway and ataxia-telangiectasia mutated, and 
Rad3-related (ATR)-Chk1 pathway are required for phosphorylation and cytoplasmic 
sequestration and/or inhibition of cdc25C, a phosphatase that performs activatory 
dephosphorylation of cyclin-dependent kinase 1 (cdk1) [8, 9]. 
     Compared to the absolute requirement for cell cycle checkpoint, ATM plays a 
relatively minor role in DSB repair. It is estimated that ATM contributes to 10-15% of 
total DSB repair both in G0/G1 and G2 [12, 13]. In G0/G1, ATM is involved in a subset 
(~10%) of DSB repair by classical non-homologous end-joining (NHEJ), which is 
dependent on KU70/80 heterodimer, DNA-dependent protein kinase catalytic subunit 
(DNA-PKcs), and XLF/XRCC4/Ligase IV complex [12, 14]. In G2, ATM is required 
for DSB end resection, a prerequisite for homologous recombination, which repairs 
~15% of total DSBs arising in G2 phase. [13]. 
     As described above, ATM is involved in both checkpoint and DSB repair, 
however, it remains unknown how ATM utilizes its checkpoint and repair function to 
minimize translocation frequency. In the present study, we addressed the mechanism of 








2. Materials and Methods 
 
2.1. Cell culture, cell cycle synchronization at G0/G1, and irradiation 
     Normal human diploid primary fibroblasts (HE49) and hTERT-immortalized 
normal human diploid foreskin fibroblasts (BJ-hTERT) were cultured in minimum 
essential Eagle’s media (MEM) supplemented with 10% fetal bovine serum (Thermo 
Fisher Scientific, USA). We observed no dicentric chromosomes both in HE49 and 
BJ-hTERT when we analyzed 100 metaphase cells. For cell cycle synchronization at 
G0/G1 phase, cells were cultured for at least two weeks from plating of 1 x 106 cells or 
more in a T25 flask (25 cm2). Cell cycle synchronization was confirmed by 
immunofluorescence staining of bromodeoxyuridine (BrdU) and phosphorylated 
histone H3 at Ser10, an S phase and G2/M phase marker, respectively. Gamma-ray 
irradiation was performed at room temperature (r.t.) in 137Cs gamma-ray irradiator at a 
dose rate of 1 Gy/min.  
 
2.2. Chemical Inhibitors 
     ATM inhibitor (KU55933, Calbiochem, Germany), Chk1/2 inhibitor (SB218078, 
Tocris Bioscience, UK), and DNA-PK inhibitor (NU7441, Tocris Bioscience, UK) were 
treated at a final concentration of 5 µM, 2.5 µM, and 1 µM, respectively. The efficacy 
of the above inhibitors, including inhibition of cell cycle checkpoint and/or DSB repair, 
is well established as described elsewhere [15-17]. 
 
2.3. Whole chromosome painting (WCP)-FISH 
     Probes for WCP-FISH were obtained from Cambio, UK. Before hybridization, 
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the probes were predenatured at 72 ˚C for ≥30 min in thermal cycler. Cells on slide 
glass were pretreated for 10 min at r.t. with ethylene glycol bis[succinimidylsuccinate] 
(EGS, Thermo Fisher Scientific, USA), a protein crosslinker, at a final concentration of 
0.2 mM in 1 x PBS- to make chromosome morphology more resistant to subsequent 
denaturation by formamide. After brief washing with 1 x PBS-, cells were permeabilized 
with 4 x SSC/0.05% Tween 20 for 2 min at r.t. After brief washing with 1 x PBS-, the 
slide glass was immersed in 70% formamide/2 x SSC for 3 min at 64.5 ˚C to denature 
DNA, followed by brief washing in 2 x SSC. After brief drying, 5 µl of predenatured 
probe solution was applied onto the center of the metaphase spread, and a coverslip was 
applied on it to avoid drying. Then, the slide glass was incubated on preheated plate (80 
˚C) for 3 min, and hybridization was performed for ≥2 hr at 37 ˚C in a dark humidified 
incubator. After hybridization, the slide glass was washed twice with 50% formamide/1 
x SSC, then, washed twice with 1 x SSC, followed by washing once with 4 x 
SSC/0.05% Tween 20. The washing was performed at 42 ˚C. After washing, 
biotin-labeled probes were fluorescently labeled with strepavidin-Cy5. Chromosomes 
were stained with DAPI.  
 
2.4. Centromere/telomere FISH 
     Peptide nucleic acid (PNA) probes for centromere and telomere were purchased 
from PANAGENE (Korea). Centromere probes were labeled with Cy3, and telomere 
probes were labeled with Cy5 or FITC. Both probes were diluted with hybridization 
buffer (70% formamide, 10% blocking protein, 20 mM maleic acid, 30 mM NaCl), so 
that the probes’ final concentration was 1.6 µg/ml. First, dried slide glass was briefly 
washed in 1 x PBS-. Then, the slide glass was immersed in 4% formalin/1 x PBS- for 2 
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min, followed by brief washing x 3 in 1 x PBS-. After brief drying, 10 µl of the above 
diluted probe solution was applied onto the center of metaphase spread, and a coverslip 
was applied on it to avoid drying. Then, the slide glass was incubated on preheated plate 
(80 ˚C) for 3 min, followed by hybridization in a dark box for ≥2 hr. Then, the slide 
glass was washed 15 min x 2 in 70% formamide/TE buffer, and washed 15 min x 2 in 
TE buffer/0.15 M NaCl/0.05% Tween 20. Chromosomes were stained with DAPI. All 
the procedures except denaturation were performed at r.t. 
 
Methods for lentivirus infection, establishment of shRNA-expressing cells, induction of 
ATM shRNAs, and chromosome sample preparation are presented in Online 






3. Results and Discussion 
 
3.1. ATM kinase suppresses frequency of translocation and dicentric induced by IR 
 
     We used ionizing radiation (IR) to generate chromosome trasnlocation, since IR is 
a well-established inducer of DSBs and chromosome rearrangements, including 
translocation [2]. In addition, we irradiated confluent-, G0/G1-synchronized cells 
because most cells in human body are in G0/G1 phase and translocation is a 
chromosome-type aberration, which should be formed before DNA replication [2]. We 
confirmed that cells irradiated in S phase rarely have translocations at first mitosis after 
IR (Supplementary Fig. 1). We also confirmed G2-irradiated cells have no dicentric, a 
chromosome aberration which occurs with equal frequency and by identical mechanism 
to translocation, at first mitosis after IR (data not shown) [18, 19]. First we examined 
whether chemical inhibition of ATM kinase activity affects translocation frequency (Fig. 
1). Confluent normal human primary fibroblasts, which have no spontaneous 
translocation, were irradiated with 2 Gy of gamma-rays in the presence of ATM 
inhibitor or its vehicle DMSO, and immediately harvested and replated at low density to 
allow cell cycle progression to mitosis (data not shown, Fig. 1A). Colcemid (0.1 µg/ml) 
was treated from immediately after replating to the time of metaphase harvest to 
accumulate first mitotic cells after IR. ATM inhibitor or DMSO was also treated from 
immediately after replating to the time of metaphase harvest. Forty-hours after replating, 
mitotic cells were harvested and analyzed by whole chromosome painting (WCP)-FISH 
probing chromosome #1~6. Typical images of translocation and dicentric are shown in 
Fig. 1B. Translocation has a constriction, and dicentric has two constrictions, indicating 
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that they have one or two centromere(s), respectively (Fig. 1B). We found that ATM 
inhibition increased frequency of both translocation and dicentric involving 
chromosome #1~6 by 4~5-fold, and translocation frequency and dicentric frequency are 
quite similar irrespective of ATM inhibition (Fig. 1C). Moreover, we obtained evidence 
that ATM kinase can suppress translocation frequency through multiple cell generations 
as translocation frequency at second mitosis was decreased by 40-50% when ATM 
kinase activity was restored from first to second mitosis, compared to continuous ATM 
inhibition until second mitosis (Supplementary Fig. 2). In contrast, dicentric frequency 
at second mitosis was much lower than at first mitosis irrespective of restoration of 
ATM activity, which is consistent with the notion that dicentric disappears through cell 
division (Supplementary Fig. 2) [2]. Based on the results in Fig. 1 and Supplementary 
Fig. 2, we conclude that at first mitosis after IR, dicentric frequency reflects 
translocation frequency, and we determined to analyze dicentric to know the frequency 
of translocation events in a whole genome until first mitosis after IR in the following 
experiments. Next, we performed centromere/telomere FISH to detect dicentric, 
because dicentric can be unambiguously detected by two centromere signals between 
two paired telomere signals (Fig. 2A, right image). Mode of DSB-induced dicentric 
formation and typical images of normal chromosomes and dicentric detected by 
centromere/telomere FISH are shown in Fig. 2A. We examined the effect of ATM 
inhibition or depletion on dicentric frequency in another normal human diploid 
fibroblasts (BJ-hTERT), which have no spontaneous dicentric (data not shown, Fig. 2B 
and 2C). We observed approximately two-fold increase in dicentric frequency in 
ATM-inhibited cells, compared to control (Fig. 2C). We employed 
doxycycline-inducible shRNA expression system to efficiently deplete ATM protein in 
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confluent cells (Fig. 2B and 2D, see Supplementary Materials and Methods). We found 
expression of two independent shRNAs (sh #1 and sh #2) against ATM mRNA also 
increased dicentric frequency by 2~2.5-fold (Fig. 2C). Based on the results in Fig. 2, we 
conclude that ATM-dependent suppression of dicentric frequency is mainly attributable 
to ATM’s kinase activity. 
 
3.2. ATM/p53-dependent G1 checkpoint contributes to suppression of dicentric 
frequency 
 
     To dissect ATM’s checkpoint role in suppression of dicentric frequency, we 
examined the effect of RNAi-mediated knockdown of p53, because p53 is a critical 
downstream effector of ATM to induce and sustain G1 checkpoint after IR [8, 9]. Indeed, 
p53 shRNA blocked 2 Gy-induced G1 arrest similarly to ATM inhibitor (cf. Fig. 3A and 
3B). Efficient knockdown of p53 by shRNA was confirmed by western blotting (Fig. 
3C). Confluent normal human fibroblasts (BJ-hTERT) expressing either control shRNA 
(shRNA against EGFP mRNA) or p53 shRNA were irradiated with 2 Gy, and after 
release from synchronization, first mitotic cells were harvested and analyzed by 
centromere/telomere FISH (Fig. 3D). The FISH analysis revealed that p53 depletion 
caused approximately 1.5-fold increase in dicentric frequency, compared to control (Fig. 
3E). We also examined the effect of abrogation of G1 checkpoint maintenance on 
frequency of translocation and dicentric (Supplementary Fig. 3). Transfection of p53 
siRNA immediately after irradiation was sufficient to abrogate G1 checkpoint 
maintenance, because BrdU incorporation of 2 Gy-irradiated cells recovered to control 
level by 40 hr after irradiation (Supplementary Fig. 3A-C). The delayed p53 depletion 
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increased dicentric frequency by approximately 1.5-fold (Supplementary Fig. 3D). We 
also performed WCP-FISH for chromosome #1~6 using the same sample as in 
Supplementary Fig. 3D, and found the delayed p53 knockdown elevates frequency of 
both translocation and dicentric (Supplementary Fig. 3E). Further, we obtained evidence 
that p53 arrests only dicentric-positive cells with unrepaired DSBs, such as terminal 
deletion or acentric fragments lacking telomere signals, because p53 shRNA increased 
percentage of dicentric-positive cells with such unrepaired DSBs by >3-fold, compared 
to control shRNA, while the p53 depletion did not affect percentage of 
dicentric-positive cells without unrepaired DSBs (Supplementary Fig. 4). In contrast to 
p53-dependent G1 checkpoint, Chk1/2-dependent intra-S, and G2 checkpoint do not 
seem to impact on dicentric frequency at least in our system (G0/G1-irradiation, release 
from synchronization, and analysis of first mitosis after IR), because Chk1/2 inhibitor 
did not affect dicentric frequency in the context of p53 depletion (Fig. 3F). From the 
same reason, it seems unlikely that Chk2-dependent transient delay of S phase entry at 
early times after IR affects dicentric frequency [8-10]. Based on the results in Fig. 3 and 
Supplementary Fig. 3-4, we conclude that ATM/p53-dependent G1 checkpoint 
contributes to suppression of dicentric frequency at first mitosis after IR. 
 
3.3. ATM suppresses dicentric frequency in the same pathway as DNA-PKcs. 
     We noticed that dicentric frequency in ATM-inhibited cells or ATM-depleted cells 
is reproducibly higher than that in p53-depleted cells (cf. Fig. 2C and Fig. 3E). To know 
whether ATM also suppresses dicentric frequency independently of its checkpoint role, 
we examined the effect of ATM inhibition on dicentric frequency in the presence of p53 
shRNA and Chk1/2 inhibitor. Confluent BJ-hTERT cells expressing p53 shRNA were 
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irradiated with 2 Gy in the presence of either Chk1/2 inhibitor alone or Chk1/2 inhibitor 
and ATM inhibitor (Fig. 4A). Immediately after irradiation, cells were replated at low 
density and were cultured for 40 hr in the presence of either colcemid/Chk1/2 inhibitor, 
or colcemid/Chk1/2 inhibitor/ATM inhibitor, followed by metaphase harvest and 
centromere/telomere FISH analysis (Fig. 4A). We found that ATM inhibitor slightly but 
reproducibly increased dicentric frequency in the context of p53 depletion and Chk1/2 
inactivation, indicating that ATM has some role in suppressing occurrence of dicentric 
independently of p53/Chk1/Chk2-dependent cell cycle checkpoints (Fig. 4B). It is 
reported that inactivation of classical NHEJ by knockout of KU70, XRCC4, or Ligase 
IV leads to elevated frequency of chromosome translocation [20-22]. Therefore, we 
reasoned that ATM cooperates with classical NHEJ factors to suppress occurrence of 
translocation. To test this, we used chemical inhibitors for ATM and DNA-PKcs, a 
classical NHEJ factor, to analyze epistasis between ATM and DNA-PKcs in suppression 
of dicentric frequency (Fig. 4C). In the presence of p53 shRNA and Chk1/2 inhibitor, 
chemical inhibition of DNA-PKcs increased dicentric frequency by >2.5-fold, 
compared to mock-treatment, indicating that kinase activity of DNA-PKcs suppresses 
dicentric frequency (Fig. 4D left, cf. Fig. 4B, ATM inhibitor (-)). Next we asked 
whether ATM inhibition shows additional effect on dicentric frequency in the context of 
DNA-PKcs inhibition (Fig. 4C). We found that ATM inhibition did not affect dicentric 
frequency in DNA-PKcs-inhibited cells (Fig. 4D). These results indicate that kinase 
activity of ATM and DNA-PKcs functions in a common pathway to suppress dicentric 
frequency.  
     It is well established that kinase activity of DNA-PKcs is crucial for DSB repair 
by classical NHEJ, however, to our knowledge, this is the first study to demonstrate that 
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kinase activity of DNA-PKcs is essential for suppression of translocation frequency [23]. 
It is consistent with the previous studies showing that deficiency of other classical 
NHEJ factors, such as KU70 and XRCC4, causes elevated translocation frequency [21, 
22]. Therefore, it is likely that persistence of unrepaired DSBs due to inactivation of 
classical NHEJ attracts other-, translocation-prone repair activity. Riballo et al. 
demonstrated that ATM acts in a subset of DSB repair pathway that requires kinase 
activity of DNA-PKcs [12]. We consider that the epistasis between ATM and 
DNA-PKcs in DSB repair can explain the epistasis between the two molecules in 
suppression of dicentric frequency, because they function in a common pathway to 
minimize unrepaired DSBs, which otherwise are repaired by classical 
NHEJ-independent-, translocation-prone pathway. We also think that milder repair 
defect conferred by ATM inhibition can explain milder increase in dicentric frequency 
compared to DNA-PKcs inhibition, because less DSBs remain unrepaired in 
ATM-inhibited cells than in DNA-PKcs-inhibited cells [12]. Molecular analysis of 
translocation breakpoint junction indicates that microhomology-mediated end-joining 
(MMEJ), which is also called alternative NHEJ, is a major DSB repair pathway that 
generates translocation [21, 22, 24]. MMEJ requires 5’-3’ resection of DSB ends for 
microhomology search, and it is recently reported that resection factors, such as MRE11 
and CtIP, are involved in MMEJ [25-28]. Indeed, Zhang and Jasin reported that CtIP 
depletion decreases translocation frequency both in wild-type and KU70(-/-) murine ES 
cells [29]. Therefore, MRE11 and CtIP are the most plausible candidates to perform 
translocation-prone MMEJ and increase dicentric frequency when ATM is inhibited or 
depleted. Importantly, ATM is recently shown to suppress MRE11-dependent DSB end 
resection and MMEJ, and the ATM-dependent suppression of resection requires its 
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kinase activity [30].  
     Our study shows that ATM/p53-dependent G1 checkpoint contributes to 
suppression of dicentric frequency, and p53 arrests dicentric-positive cells with 
unrepaired DSBs (Fig. 3 and Supplementary Fig. 4). Therefore, ATM/p53-dependent G1 
checkpoint stands as a “safeguard”, when classical NHEJ does not work properly and 
more DSBs are converted to translocation. G1 checkpoint is highly sensitive, which can 
be induced by a single DSB [31]. We previously showed that growth of an IR-induced 
focus of checkpoint factors, such as Ser1981-phosphorylated ATM and 53BP1, allows 
damage signal of a single DSB to be amplified to a sufficient level to elicit G1 
checkpoint [32]. Therefore, cells harboring translocation can be arrested if they have 
only one unrepaired DSB.  
     Based on lines of evidence presented by us and others described above, it is likely 
that ATM has a dual role to minimize translocation frequency; one is suppression of 
translocation-prone repair pathway, e.g. MMEJ, and the other is induction and 
maintenance of G1 checkpoint in translocation-positive cells with unrepaired DSB(s). 
We believe that such great contribution to translocation suppression can partly explain 
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Figure 1  
ATM kinase suppresses frequency of ionizing radiation-induced chromosome 
translocation and dicentric.  
A. Schematic representation of Fig. 1 experiment.  
B. Images of translocation and dicentric. Typical images of translocation and dicenric 
involving chromosome #1 are shown.  
C. Effect of ATM inhibition on frequency of translocation and dicentric involving 
chromosome #1~6. Average number of translocation or dicentric per cell from two 
independent experiments is shown. Fifty metaphase cells were scored in each 
experiment. Error bars represent standard deviation. Note that frequency is similar 




Figure 2  
Analysis of dicentric frequency by centromere/telomere FISH in ATM-inhibited or 
depleted cells. 
A. Mode of DSB-induced dicentric formation and typical images of normal 
chromosomes and dicentric detected by centromere/telomere FISH. 
B. Schematic representation of Fig. 2C experiments.  
C. Effect of ATM inhibition or depletion on dicentric frequency. Average number of 
dicentric per cell from two independent experiments was shown. Fifty metaphases 
were scored in each experiment. Error bars represent standard deviation. 
D. ATM depletion by doxycycline-inducible shRNA expression system. +Dox indicates 





Figure 3.  
ATM/p53-dependent G1 checkpoint suppresses dicentric frequency. 
A. Effect of ATM inhibition on IR-induced G1 checkpoint. Confluent BJ-hTERT cells 
were mock-irradiated or irradiated with 2 Gy in the presence of ATM inhibitor or 
DMSO, followed by replating at low density into media containing either ATM 
inhibitor/BrdU (10 µM) or DMSO/BrdU. Forty-hours later, cells were fixed and 
subjected to immunofluorescence staining for BrdU. Average from two independent 
experiments is shown, and at least 2000 cells were scored in each sample. Error bars 
represent standard deviation.  
B. Effect of p53 depletion on IR-induced G1 checkpoint. Confluent BJ-hTERT cells 
expressing p53 shRNA or control shRNA (EGFP shRNA) were mock-irradiated or 
irradiated with 2 Gy, followed by replating at low density into media containing 
BrdU. BrdU-positive cells were analyzed as in Fig. 3A.  
C. Depletion of p53 protein by shRNA. Depletion of p53 was confirmed by western 
blotting. 
D. Schematic representation of Fig. 3E and 3F experiments.  
E.  Effect of p53 depletion on dicentric frequency. Average number of dicentric per cell 
from two independent experiments is shown. Fifty metaphase cells were scored in 
each experiment. Error bars represent standard deviation. 
F.  Effect of Chk1/2 inhibitor on dicentric frequency in the context of p53 depletion. 
Chk1/2 inhibitor was treated from 30 min before IR to the time of metaphase harvest. 




Figure 4.  
ATM suppresses dicentric frequency in the same pathway as DNA-PKcs.  
A.  Schematic representation of Fig. 4B experiments. 
B.  Effect of ATM inhibition on dicentric frequency in the context of p53 depletion and  
   Chk1/2 inhibition. Average number of dicentric per cell from two independent  
   experiments is shown. Fifty metaphase cells were scored in each experiment. Error  
   bars represent standard deviation. 
C.  Schematic representation of Fig. 4D experiments. 
D.  Effect of DNA-PKcs inhibition or DNA-PKcs/ATM double-inhibition on dicentric 
frequency in the context of p53 depletion and Chk1/2 inhibition. Average number of 
dicentric per cell from two independent experiments is shown. Fifty metaphase cells 
were scored in each experiment. Error bars represent standard deviation. 
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Supplementary Materials and Methods 
      
1. Lentivirus infection, establishment of shRNA-expressing cells, and induction of ATM 
shRNAs 
     Lentivirus vectors expressing shRNAs for ATM or enhanced green fluorescent 
protein (EGFP) were purchased from Thermo Fisher Scientific, USA. Kinds of 
lentivirus vectors and their clone ID or catalog number are as follows: ATM shRNA #1 
(TRIPZ shRNAmir, clone ID V2THS_89368) , ATM shRNA#2 (TRIPZ shRNAmir, 
clone ID V2THS_192880), EGFP shRNA (pLKO.1, RHS4459). A lentivirus vector 
expressing p53 shRNA (shp53 pLKO.1 puro) was provided by Dr. Robert Weinberg 
through Addgene (USA) (Addgene plasmid 19119) [1]. For virus production, 
shRNA-expressing vector (8 µg) was cotransfected with packaging vector 
(pCMV-dR8.74, 8 µg) and envelope vector (pMD2.G, 8 µg) into 293T cells (8-9 x 106) 
with Lipofectamine 2000 (Invitrogen), and cells were cultured for 8~10 hr, followed by 
media change and culture for additional 48 hr. Then, the supernatant of the culture 
media containing virus was collected and passed through 0.45 µm filter. For virus 
infection, the filtered supernatant was then either directly treated (for ATM shRNA) or 
treated with a dilution ratio of 1:10~100 onto cells (for p53 shRNA and EGFP shRNA), 
which were plated (3 x 105 cells/T25 flask) a day before infection. The virus infection 
was performed for 12-15 hr in humidified CO2 incubator at 37˚C. After infection, cells 
were washed twice with 1 x PBS-, then cultured for 3 days, followed by puromycin 
selection for 1-2 weeks. Final concentration of puromycin for selection was 15 µg/ml 
for ATM shRNA-expressing cells, and 1 µg/ml for p53 shRNA-, or EGFP 
shRNA-expressing cells. ATM shRNAs were induced by treatment of doxycycline (2 
 31
µg/ml) for 7 days. 
 
2. Chromosome sample preparation 
     Confluent cells were irradiated with 2 Gy of gamma-rays and harvested by 
trypsinization and replated at low density (2~2.5 x 106 cells in T75 flask) immediately 
after irradiation to allow cell cycle progression to mitosis. Colcemid (0.1 µg/ml) was 
continuously treated from the time of replating to the time of metaphase harvest (40 hr 
after replating) to accumulate first metaphase cells. Metaphase cells were harvested by 
brief washing with 1 x PBS- and trypsin, followed by tapping of a flask. After 
centrifugation (1,200 rpm, 5 min) of cell suspension and washing by 1 x PBS-, cells 
were treated with hypotonic buffer (0.075 M KCl) for 20 min at r.t., followed by 
fixation with Carnoy’s fixative (methanol : acetic acid = 3 : 1) on ice for ≥30 min. After 
fixation, cells were resuspended with appropriate volume of Carnoy’s fixative, and the 
cell suspension was dropped onto a 70%-ethanol-immersed slide glass. The slide glass 
was dried for at least 1 day in dessicator (humidity ≤ 30%), and was subjected to whole 
chromosome painting (WCP)-FISH, or centromere/telomere FISH. 
 
Reference 
1. S. Godar, T.A. Ince, G.W. Bell, Growth-inhibitory and tumor- suppressive functions  






Supplementary Figure legends 
 
Supplementary Figure 1 
Cells irradiated in S phase rarely have translocation or dicentric at first mitosis after 
irradiation. 
 
A. Schematic representation of Supplementary Figure 1 experiment. S phase cells of 
exponentially-growing normal human primary fibroblasts were labeled with 
bromodeoxyuridine (BrdU, 10µM) for 1 hr prior to irradiation. Then, cells were 
washed with fresh media to remove BrdU, followed by 2 Gy-irradiation in the 
presence of Chk1/2 inhibitor and ATM inhibitor. Chk1/2 inhibitor and ATM inhibitor 
were used because otherwise S phase cells cannot progress to mitosis probably due 
to intra-S, and G2 checkpoint. Colcemid (0.1 µg/ml) was treated for 6 hr before 
metaphase harvest to accumulate BrdU-positive metaphase cells. Ten hours after 
irradiation, mitotic cells were harvested and analyzed by centromere/telomere FISH 
or WCP-FISH probing chromosome #1, 2, and 3. 
B. Typical image of BrdU-positive metaphase cells probed by centromere/telomere 
FISH. BrdU, centromeres, telomeres, and chromosomes were stained green, red, 
white, and blue, respectively. Note the uneven BrdU staining on chromosomes, 
indicating that there were both replicated and unreplicated DNA regions at the time 
of irradiation. 
C. Typical image of BrdU-positive metaphase cells probed by WCP-FISH for 
chromosome #3. BrdU, chromosome #3, and chromosomes were stained green, red, 
and blue, respectively. Note the uneven BrdU staining on chromosomes, indicating 
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that there were both replicated and unreplicated DNA regions at the time of 
irradiation. 
D. Frequency of dicentric or translocation involving chromosome #1, 2, or 3. Dicentric 




Supplementary Figure 2 
ATM can suppress translocation frequency through multiple cell generations. 
 
A. Schematic representation of Supplementary Figure 2 experiment. Confluent normal 
human primary fibroblasts were irradiated with 2 Gy of gamma-rays in the presence 
of ATM inhibitor, followed by trypsinization and replating at low density into media 
containing ATM inhibitor. We observed that many cells enter first mitosis 40 hr after 
replating and second mitosis 72 hr after replating (data not shown). Forty-hours after 
replating, cells were either washed to remove ATM inhibitor or kept treated with 
ATM inhibitor, and cultured until 72 hr after replating. Colcemid (0.1 µg/ml) was 
treated for 6 hr before metaphase harvest. Seventy-two hours after replating, when 
many cells enter second mitosis, metaphase cells were harvested and analyzed by 
WCP-FISH probing chromosome #1-6. 
B. Effect of restoration of ATM kinase activity on the frequency of translocation and  
  dicentric at second mitosis after G0/G1-irradiation. Average number of translocation  
  or dicentric per cell from two independent experiments is shown. At least 30  
  metaphase cells were scored in each experiment. The left-most bars indicate   
  frequency of translocation and dicentric at first mitosis after irradiation which is  
  presented in Figure 1C. Note the lower translocation frequency in the population    
  where ATM kinase activity was restored from first mitosis to second mitosis after  
  irradiation, compared to the population where ATM activity was inhibited until  
  second mitosis. Also note the much lower dicentric frequency at second mitosis than  
  at first mitosis, irrespective of restoration of ATM kinase activity.  
 35
Supplementary Figure 3 
Maintenance of p53-dependent G1 checkpoint is critical for suppression of 
translocation-, and dicentric frequency. 
 
A. Schematic representation of Supplementary Figure 3D and 3E experiments.  
Confluent normal human primary fibroblasts were irradiated with 2 Gy of 
gamma-rays, and immediately after irradiation, cells were harvested and transfected 
with either p53 siRNA or control siRNA. Then, cells were replated at low density to 
allow cell cycle progression to mitosis. Colcemid was treated from immediately after 
replating to the time of metaphase harvest to accumulate first mitosis after irradiation. 
Forty-hours after replating, metaphase cells were harvested and analyzed by 
centromere/telomere FISH in Supplementary Figure 3D and by WCP-FISH probing 
chromosome #1-6 in Supplementary Figure 3E.  
B. Effect of p53 siRNA transfection after irradiation on G1 checkpoint maintenance.  
Confluent normal human primary fibroblasts were mock-irradiated or irradiated with 
2 Gy of gamma-rays, and immediately after irradiation, cells were harvested and 
transfected with either p53 siRNA or control siRNA. Then, cells were replated at low 
density into BrdU-containing media to allow cell cycle progression to mitosis. 
Forty-hours after replating, cells were fixed and subjected to immunofluorescence 
staining for BrdU. Average from two independent experiments is shown, and at least 
2000 cells were scored in each sample. Error bars represent standard deviation. Note 
that percentage of BrdU-incorporated cells is similar between unirradiated cells and 
irradiated cells in the presence of p53 siRNA, indicating that p53 siRNA transfection 
after IR is sufficient for abrogation of G1 checkpoint maintenance.  
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C. Depletion of p53 protein by siRNA. Confluent normal human primary fibroblasts 
were irradiated with 2 Gy of gamma-rays, and immediately after irradiation, cells 
were harvested and transfected with either p53 siRNA or control siRNA. Then, cells 
were replated at similar density to Supplementary Figure 3D and 3E experiments, 
and forty-hours later, total cellular proteins were collected and subjected to western 
blotting for p53 and α/β-tubulin.  
D. Effect of delayed p53 depletion on dicentric frequency. Average number of dicentric 
per cell from two independent experiments is shown. Fifty metaphase cells were 
scored in each experiment. Error bars represent standard deviation. Note that the p53 
siRNA transfection after irradiation increased dicentric frequency similarly to 
constitutive p53 depletion from before irradiation in Fig. 3E (both ways of p53 
depletion caused approximately 1.5 fold increase in dicentric frequency).  
E. Effect of delayed p53 depletion on frequency of translocation and dicentric involving  
chromosome #1~6. The same samples as in Supplementary Fig. 3D were analyzed 
by WCP-FISH probing chromosome #1~6. Analysis and data display were 
performed as in Fig. 1C.  
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Supplementary Figure 4 
p53 suppresses dicentric-positive cells with unrepaired DSBs to progress to mitosis.  
 
A. Typical images of chromosome aberrations detected by centromere/telomere FISH. 
   In centromere/telomere FISH, a normal chromosome has a centromere signal and  
   two paired telomere signals at both chromosome ends as indicated in Fig. 2A.  
   Therefore, in the analysis of Supplementary Figure 4B, chromosomes or acentric  
   fragments lacking telomere signal(s), such as terminal deletion or acentric fragment  
   with ≤ 3 telomeres were regarded as unrepaired DSBs. Acentric fragments with 4  
   telomeres were regarded as repaired DSBs.  
B. Frequency of dicentric-positive cells with or without unrepaired DSBs in 
p53-depleted cells. The same chromosome samples as in Fig. 3E were analyzed. 
Percentage of dicentric-positive cells with or without unrepaired DSBs, which are 
defined in Supplementary Figure 4A, is shown. Average percentage from two 
independent experiments is indicated, and 50 metaphase cells were scored in each 
experiment. Note that p53 depletion increased only dicentric-positive cells with 
unrepaired DSBs, while percentage of dicentric-positive cells without unrepaired 
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